MedTrace Logo

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs

NCT04928300 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-02

No results posted yet for this study

Summary

In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.

Conditions

  • Rib Fractures

Interventions

DRUG

Dexmedetomidine

low dose dexmedetomidine infusion 0.2 µ/kg/hour IV for 5 days.

OTHER

0.9% saline

the same dose and duration of normal saline will be given for 5 days.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Omar Soliman, MD · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-12
Primary Completion
2027-07-01
Completion
2027-07-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04928300 on ClinicalTrials.gov